{"tid":2319215,"cid":15,"subCid":0,"title":"[純投機] ALXO 技術面轉好","createTime":"2020-12-10T02:38:46.000Z","updateTime":"2020-12-10T02:51:43.000Z","uid":190320,"like":0,"dislike":0,"uniUserReply":2,"replies":[{"pid":"48165eaebf84b1b317ef6ebaeaf044dfdf5b8036","tid":2319215,"uid":190320,"like":0,"dislike":0,"score":0,"citedBy":0,"replyTime":"2020-12-10T02:38:46.000Z","msg":"ALX Oncology Holdings Inc是一家臨床階段的免疫腫瘤公司。 該公司專注於開發可阻斷CD47檢查點途徑並橋接先天性和適應性免疫係統的療法。<br />\n<img src=\"https://na.cx/i/xPr96ex.jpg\" data-thumbnail-src=\"https://i.lih.kg/thumbnail?u=https%3A%2F%2Fna.cx%2Fi%2FxPr96ex.jpg&h=12f8f899&s={SIZE}\" /><br />\n<br />\n<br />\n有無巴打有留意呢隻???<br />\n如果真係開發到治療癌症藥物<br />\n潛力真係好大<br />\n現時市值3.03B, <br />\n博佢仲有上升空間,<br />\n不過Biotechnology 同行真係超多好難睇得哂<br />\n利伸: 打算今晚買100股坐下"},{"pid":"4b72655ff7464f449829f6e62e4f64f990ff4583","tid":2319215,"uid":64131,"like":1,"dislike":0,"score":1,"citedBy":1,"replyTime":"2020-12-10T02:40:37.000Z","msg":"乜撚嘢eat me dont eat me"},{"pid":"9e0c81b3a8a84d9570dc77c029f226879616edaa","tid":2319215,"uid":190320,"like":0,"dislike":0,"score":0,"quote":{"pid":"4b72655ff7464f449829f6e62e4f64f990ff4583","tid":2319215,"uid":64131,"like":1,"dislike":0,"score":1,"citedBy":1,"replyTime":"2020-12-10T02:40:37.000Z","msg":"乜撚嘢eat me dont eat me"},"citedBy":0,"replyTime":"2020-12-10T02:51:43.000Z","msg":"<img src=\"/assets/faces/big/sosad.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/big/sosad.gif\" class=\"hkgmoji\" /><img src=\"/assets/faces/big/sosad.gif\" class=\"hkgmoji\" />"}]}